1-6 of 6
Arthur Moellmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Financial Impact of Imatinib Discontinuation in Brazil - a Pharmoeconomic Study

Renato Torrescasana Centrone, Isabel Bonafe, Eliana C Miranda, PhD, Fernanda S Seguro, MD, Gustavo HR Magalhaes, MD MSc, Nelma D Clementino, MD, Arthur Moellmann-Coelho, MD, Ingrid Luise, MD, Monika Conchon, MD, Natália N Gonçalves, MD, Jaisson Bortolini, MD, Laura Maria Fogliatto, MD PhD, Carmino Antonio Souza, MD PhD, Katia B Pagnano, MD PhD, Israel Bendit, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5844.
https://doi.org/10.1182/blood-2019-127530
Published: 2019
Journal Articles

Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia - a Multicenter, Observational Study

Katia B Pagnano, MD, Carmen Fava, Eliana C Miranda, Israel Bendit, MD PhD, Fernanda S Seguro, MD, Gustavo HR Magalhaes, MD, Nelma D Clementino, MD, Monika Conchon, MD, Natália N Gonçalves, MD, Gianluca Gaidano, MD PhD, Monia Lunghi, MD PhD, Arthur Moellmann-Coelho, MD, Ingrid Luise, MD, Micaela Bergamaschi, MD, Dario Ferrero, MD, Renato Centrone, MD, Patrizia Pregno, Laura Fogliatto, Valentina Giai, Matteo Emidio Dragani, MD, Elena Moiraghi, Jaisson Bortolini, MD, Andrea Castelli, Alessandra Cuttica, MD, Teresa Cristina Bortolheiro, MD, Cristiane Pinna, MD, Carmino Antonio De Souza, MD PhD, Giuseppe Saglio
Journal: Blood
Blood (2018) 132 (Supplement 1): 46.
https://doi.org/10.1182/blood-2018-99-113718
Published: 2018
Journal Articles

E14a2 and e14a2+e13a2 BCR-ABL Transcripts Are Associated with Earlier Cytogenetic and Molecular Response Rates in CML-CP Treated with Imatinib

Katia B Pagnano, MD, Eliana C Miranda, Fernanda S Seguro, MD, Gustavo HR Magalhaes, MD, Nelma D Clementino, MD, Arthur Moellmann-Coelho, MD, Maryanna N Da Silva, Renato Centrone, MD, Monika Conchon, MD, Jaisson Bortolini, MD, Teresa Cristina Bortolheiro, MD, Valquiria Povoa, Luciana Nardinelli, Carmino Antonio De Souza, MD PhD, Israel Bendit, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1596.
https://doi.org/10.1182/blood.V130.Suppl_1.1596.1596
Published: 2017
Journal Articles

Late Responders to Imatinib: Is Timing of Achievement of Complete Cytogenetic and Molecular Responses the Same in Previously Treated as Compared to the Newly Diagnosed CML Patients?

Vanesa Scholl, Roberta Bitencourt, Arthur Moellmann, Rocio Hassan, Moises Rocha, Jane Dobbin, Ilana Zalcberg
Journal: Blood
Blood (2008) 112 (11): 4266.
https://doi.org/10.1182/blood.V112.11.4266.4266
Published: 2008
Journal Articles

Concomitant Diagnosis of Chronic Myeloid Leukemia and B-Cell Chronic Lymphocytic Leukemia in a 57-Year-Old Female Patient, with Good Therapeutic Response Exclusively to Imatinib in Both Myeloid and Lymphoid Clones.

Arthur Moellmann-Coelho, MD, Luise Otero, Ricardo S. Bigni, MD, Denise Azambuja, MD, Claudio G. Stefanoff, Jane A. Dobbin, MD, Ilana Zalczberg
Journal: Blood
Blood (2007) 110 (11): 4583.
https://doi.org/10.1182/blood.V110.11.4583.4583
Published: 2007
Journal Articles

Peripheral Blood HPC Counts Are Augmented in CML Patients with Cytogenetic Findings of Disease as Compared to Patients in Cytogenetic Remission.

Ernesto de Meis, MD, Rita C.B. Morais, Luize O. Carvalho, Arthur Moellmann-Coelho, MD, Maria M.K. Martinez, Ana J.U.B. Costa, Ailce S. Barros, Ilda A.M. Castilho, MD
Journal: Blood
Blood (2004) 104 (11): 4691.
https://doi.org/10.1182/blood.V104.11.4691.4691
Published: 2004